Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Find Radio Compass News for Cinacalcet

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

EU WC

EU WC

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 30MG BASE
  • TABLET;ORAL - EQ 60MG BASE
  • TABLET;ORAL - EQ 90MG BASE

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-31-2024-59527.pdf

FDA
31 Jan 2024

https://www.businesswire.com/news/home/20201001005475/en/Dr.-Reddys-Laboratories-Announces-the-Launch-of-Cinacalcet-Tablets-in-the-U.S.-Market

BUSINESSWIRE
01 Oct 2020

http://www.pharmabiz.com/NewsDetails.aspx?aid=131519&sid=2

PHARMABIZ
01 Oct 2020

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213325

FDA
21 May 2020

https://www.ema.europa.eu/en/documents/overview/cinacalcet-accordpharma-epar-medicine-overview_en.pdf

EMA
15 Apr 2020

https://www.fiercepharma.com/pharma/rumors-amgen-will-buy-alexion-resurface-to-delight-investors-and-analysts

Arlene Weintraub FIERCE PHARMA
27 Aug 2019

https://endpts.com/why-would-amgen-want-to-buy-alexion-analysts-call-hotly-rumored-takeover-unlikely-but-seize-the-spotlight/

Amber Tong ENDPTS
24 Aug 2019

https://www.fiercepharma.com/pharma/amgen-sales-slide-as-sensipar-neulasta-suffer-from-generic-and-biosim-attack

Eric Sagonowsky FIERCE PHARMA
31 Jul 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210548

FDA
28 Jun 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210570

FDA
20 May 2019

https://www.fiercepharma.com/pharma/amgen-teva-strike-sensipar-patent-deal-after-brief-generic-launch

Eric Sagonowsky FIERCE PHARMA
04 Jan 2019

https://www.businesswire.com/news/home/20190102005667/en

BUSINESSWIRE
03 Jan 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204377

FDA
27 Dec 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208971

FDA
26 Nov 2018

https://www.ema.europa.eu/documents/procedural-steps-after/cinacalcet-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf

EMA
09 Oct 2018

https://www.pharmacompass.com/pdf/news/senispar-cinacalcet-hydrochloride-amgen-vs-emcure-pharmaceuticals-1536992435.pdf

PATENT LITIGATION
15 Sep 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210207

FDA
06 Aug 2018

https://www.lifesciencesipreview.com/news/amneal-obtains-non-infringement-finding-in-sensipar-case-3022?utm_source=World+IP+Review&utm_campaign=ded2754d82-LSIPR_Digital_Newsletter_31_05_2018_COPY_01&utm_medium=email&utm_term=0_d76dcadc01-ded2754d82-27561417

LIFESCIENCE PREVIEW
02 Aug 2018

https://www.fiercepharma.com/pharma/could-amgen-soften-neulasta-biosimilar-blow-alexion-buy

Carly Helfand FIERCE PHARMA
16 Jul 2018

https://www.pharmacompass.com/pdf/news/senispar-cinacalcet-hydrochloride-amgen-inc-v-accord-healthcare-inc-and-intas-pharmaceuticals-ltd-1530593445.pdf

PATENT LITIGATION
29 Jun 2018

https://www.fiercepharma.com/corporate/amgen-faces-tough-one-two-blow-as-competition-mounts-for-repatha-and-sensipar

A. Weintraub FIERCE PHARMA
14 Mar 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208915

FDA
10 Mar 2018

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206125

FDA
10 Mar 2018

http://www.mdmag.com/medical-news/fda-approves-2-cinacalcet-hydrochloride-generics-for-hpt-market-competition

K. Kunzmann MDMAG
09 Mar 2018

https://www.raps.org/news-and-articles/news-articles/2018/3/fda-approves-first-generic-versions-of-amgen%E2%80%99s-sen

Zachary Brennan RAPS
08 Mar 2018

https://www.fiercepharma.com/legal/amgen-comes-up-short-lawsuit-against-fda-sensipar-pediatric-exclusivity-as-generics-inch

E. Sagonowsky FIERCE PHARMA
22 Feb 2018

https://www.law360.com/lifesciences/articles/965940

Jimmy Hoover LAW360
21 Sep 2017

http://www.prnewswire.com/news-releases/european-commission-approves-expanded-use-of-mimpara-cinacalcet-for-the-treatment-of-secondary-hyperparathyroidism-in-children-with-end-stage-renal-disease-on-dialysis-300512398.html

PR NEWSWIRE
31 Aug 2017

http://www.prnewswire.com/news-releases/amgen-receives-positive-chmp-opinion-to-expand-use-of-mimpara-cinacalcet-for-the-treatment-of-secondary-hyperparathyroidism-in-certain-children-with-end-stage-renal-disease-on-dialysis-300479027.html

PR NEWSWIRE
23 Jun 2017

https://www.pharmacompass.com/pdf/news/sensipar-cinacalcet-hydrochloride-amgen-inc-v-piramal-healthcare-limited-1497264787.pdf

PATENT LITIGATION
09 Jun 2017

http://www.genengnews.com/gen-news-highlights/amgen-sues-to-reverse-fda-denial-of-pediatric-exclusivity-for-sensipar/81254428

GENENGNEWS
01 Jun 2017

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090539

FDA
26 Apr 2017

http://www.pmlive.com/pharma_news/nice_set_to_back_parsabiv_for_kidney_disease_complication_1188354

Phil Taylor PMLIVE
08 Mar 2017

http://www.multivu.com/players/English/8004551-amgen-parsabiv-fda-approval/

MULTIVU
07 Feb 2017

http://www.prnewswire.com/news-releases/european-commission-approves-parsabiv-etelcalcetide-for-the-treatment-of-secondary-hyperparathyroidism-in-adults-on-hemodialysis-300361522.html

PR NEWSWIRE
11 Nov 2016

http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/anvisa+aprova+genericos+ineditos+para+hiperparatiroidismo+e+antiepiletico

ANVISA
16 May 2016

https://www.pharmacompass.com/pdf/news/mylans-cinacalcet-receives-marketing-authorisation-in-eu-to-treat-secondary-hyperparathyroidism-and-reduce-hypercalcaemia-1448710183.pdf

EMA
27 Nov 2015

http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

Eric Palmer FIERCE PHARMA MFG
02 May 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy